Showing 2031-2040 of 3890 results for "".
Currents: Patient-Focused Approaches to Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-patient-focused-approaches-to-eczema/23444/Counting Our Blessings: What to Celebrate In Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/counting-our-blessings-what-to-celebrate-in-dermatology/20289/It can be tempting to lose sight of what we love about dermatology. Don't fall into the trap.Easing Further Down The Road: Getting Comfortable with MIPS
https://practicaldermatology.com/topics/practice-management/easing-further-down-the-road-getting-comfortable-with-mips/20715/Part two of a three-part series on the MIPS “pick-your-pace” transition.Invasive Melanoma: Incidence, Mortality Continue to Climb
https://practicaldermatology.com/topics/practice-management/invasive-melanoma-incidence-mortality-continue-to-climb/20780/The burden of disease is growing, despite best efforts to combat melanoma.Getting Social is Essential!
https://practicaldermatology.com/topics/practice-management/getting-social-is-essential/20888/Currents
https://practicaldermatology.com/topics/psoriasis/currents/20930/Can Vitamin B3 Reduce Recurrence of NMSC?
https://practicaldermatology.com/topics/practice-management/can-vitamin-b3-reduce-recurrence-of-nmsc/21165/A common OTC vitamin supplement shows early promise in preventing secondary NMSCs. Is it time to recommend it?New Products
https://practicaldermatology.com/columns/new-products/new-products/21167/Cloning & Coding: Another EHR Controversy Rises
https://practicaldermatology.com/topics/practice-management/cloning--coding-another-ehr-controversy-rises/21549/“Upcoding” is the latest unanticipated chapter in the long-running regulatory saga of EHRs.Take 5: Recent Developments in Systemic Therapy for Psoriasis
https://practicaldermatology.com/columns/recent-developments/take-5-recent-developments-in-systemic-therapy-for-psoriasis/22002/New data reveal noteworthy financial and clinical trends in the use of systemic agents.